Buy NSI 189

NSI-189 Phosphate is an experimental nootropic (cognitive enhancer) and antidepressant compound. It is a derivative of nicotinamide and pyrazine, two chemical compounds that contribute to its effects on neurogenesis (the growth of new brain cells) and potential mood enhancement. NSI-189 was developed by Neuralstem, Inc. for the treatment of major depressive disorder (MDD), as well as potential use in other conditions such as cognitive impairment and neurodegenerative diseases.

Key Characteristics of NSI-189 Phosphate:

1. Mechanism of Action:
   • NSI-189 Phosphate is thought to work by promoting neurogenesis in the hippocampus, a region of the brain associated with memory, emotion, and cognition. Buy NSI 189 
   • It has shown potential to increase the volume of the hippocampus in preclinical studies, which may improve cognitive function and mood. Buy NSI 189
   • Its exact mechanism of action is not fully understood, but it is believed to stimulate brain cell growth and restore neural function that may be impaired in conditions like depression and traumatic brain injury (TBI).
2. Potential Uses:
   • Major Depressive Disorder (MDD): NSI-189 was initially developed as a potential treatment for depression. Clinical trials aimed to evaluate its efficacy in alleviating depressive symptoms, especially in patients who do not respond to traditional antidepressants. Buy NSI 189 
   • Cognitive Enhancement: As a nootropic, NSI-189 is also of interest for its possible benefits in improving memory, learning, and cognitive function, particularly in individuals suffering from cognitive decline.
   • Neurodegenerative Diseases: There is ongoing interest in exploring NSI-189’s potential for treating Alzheimer’s disease, Parkinson’s disease, and other disorders where neurogenesis is disrupted.
   • Traumatic Brain Injury (TBI): Some studies have considered the potential of NSI-189 to repair brain damage and improve cognitive function after brain injuries.
3. Dosage and Administration:
   • NSI-189 Phosphate is typically administered orally, with common doses in research ranging from 20 mg to 80 mg per day.
   • It is often provided as a phosphate salt to improve bioavailability (absorption into the body) compared to its base form.
4. Clinical Trials:
   • Phase I and II clinical trials have been conducted to assess the safety and efficacy of NSI-189 for treating depression. Results have been mixed, with some studies showing modest antidepressant effects, while others failed to demonstrate statistically significant improvements.
   • Despite the varied outcomes, research into NSI-189 continues, with interest in its ability to reverse brain atrophy and stimulate neural regeneration.
5. Effects:
   • Mood Improvement: NSI-189 has been studied primarily for its antidepressant properties. Some users report enhanced mood stability and reduced anxiety.
   • Cognitive Function: Research suggests that NSI-189 may improve working memory, verbal recall, and mental clarity, particularly in people experiencing cognitive decline or depressive symptoms.
   • Neurogenesis: One of the most promising aspects of NSI-189 is its potential to stimulate brain cell growth in the hippocampus, which could translate into long-term cognitive and emotional benefits.
6. Side Effects:
   • Headaches: Some users report experiencing headaches, particularly when starting NSI-189 or at higher doses.
   • Dizziness: Dizziness and lightheadedness can occur in certain individuals.
   • Irritability: A minority of users have reported feeling irritable or emotionally “flat” while taking the compound.
   • Sleep Disturbances: Insomnia or difficulty falling asleep has been reported by some users, especially when taken later in the day.
7. Legal Status and Availability:
   • NSI-189 Phosphate is currently an investigational drug and has not been approved for general medical use by regulatory agencies like the FDA.
   • It is often sold in the nootropic market as a research chemical, where its use is legal for research purposes but not for human consumption in many countries.
8. Research and Development:
   • Ongoing research aims to better understand the mechanisms behind NSI-189’s effects, with hopes of developing new treatments for depression, cognitive disorders, and brain injuries.
   • While promising, the results from clinical trials have not yet led to widespread adoption or approval for medical use.

Conclusion:

NSI-189 Phosphate is an experimental nootropic and antidepressant that has shown potential for stimulating neurogenesis and improving cognitive function. While it has generated interest for its possible benefits in treating depression, cognitive impairment, and neurodegenerative diseases, clinical results have been mixed, and further research is needed to determine its full efficacy and safety profile.

Buy NSI 189